Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05187364 · ClinicalTrials.gov registry record · NA
BioWare for AUD and PTSD
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT05187364: Completed NA study, sponsored by Medical University of South Carolina.
NCT05187364 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05187364, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study examines the ability of an innovative telehealth technology system to enhance Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) talk-therapy for individuals with posttraumatic stress disorder (PTSD) and alcohol use disorder.
Primary Outcome
Feasibility is 80% of participants turning on and off equipment in 5 minutes or less
Interventions
- BEHAVIORAL COPE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2022-05-05 |
| Est. Completion | 2023-02-20 |
| Phase | NA |
What the finished NCT05187364 record still lists
NCT05187364 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which COPE is the first listed.
NCT05187364 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05187364 about?
NCT05187364 is a clinical study titled "BioWare for AUD and PTSD". This study examines the ability of an innovative telehealth technology system to enhance Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) talk-therapy for individuals with posttraumatic stress disorder (PTSD) and alcohol use disorder.
What is the current status of trial NCT05187364?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2022-05-05. Estimated completion is 2023-02-20.
What interventions are being tested in trial NCT05187364?
The interventions under investigation include: COPE (BEHAVIORAL).
Who is sponsoring clinical trial NCT05187364?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05187364's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI